The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes

Anne-Vibeke LaenkholmDepartment of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark; Correspondence[email protected]
View further author information

Maj-Britt JensenDanish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; View further author information

Jens Ole EriksenDepartment of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark; View further author information

Wesley BuckinghamNanoString Technologies Inc, Seattle, WA, USA; View further author information

Sean FerreeNanoString Technologies Inc, Seattle, WA, USA; View further author information

Torsten O. NielsenDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; View further author information

Bent EjlertsenDanish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; ;Danish Breast Cancer Cooperative Group, Department of Oncology, Rigshospitalet, Copenhagen, DenmarkView further author information

show all

The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes

Anne-Vibeke_Laenkholm_et_al._Supplementary_Figure_1.tif

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes

Anne-Vibeke_Laenkholm_et_al._Supplementary_Figure_1.tif

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date